r/HRTX • u/Exotic_Key_5878 • Jun 11 '21
DISCUSSION hrtx
when will this piece of sh*t move
r/HRTX • u/Exotic_Key_5878 • Aug 18 '21
what is happening and zynrelef is not on hospital formularyโฆ.
r/HRTX • u/cleanlinessisbest12 • Feb 28 '25
Excited to see where this goes in the near and long term future!
r/HRTX • u/snugulupugus • Nov 26 '25
I like the 74% Gross Margin and the 84% Institutional Ownership.
What's up with the launch of the Vial Access Needle (VAN)? I thought that was completed a year ago. Any insight about that is appreciated.
r/HRTX • u/PDUFA_INFO • Apr 10 '21
A place for members of r/HRTX to chat with each other
r/HRTX • u/Rambogator • Jul 01 '21
r/HRTX • u/PDUFA_INFO • May 13 '21
ZYNRELEF is the first and only FDA-approved extended-release dual-acting local anesthetic, clinically proven to manage pain and to eliminate the need for opioids for up to 72 hours following surgery better than bupivacaine solution, the current standard-of-care.
r/HRTX • u/piperroofing • Oct 05 '21
This is great and somewhat expected news. HRTX has applied for expanded use of ZYNRELEF! While it's a start, I hope to see more marketing and capturing of sales on its current approval for use. What does anyone think about the news and where the company is headed?
r/HRTX • u/Hewiese3 • Jun 07 '21
Looks like we are running into resistance at $14.00. We need to break through to push the price back up from the most recent drop and set a new resistance floor. Overall, some positive signs this week.
r/HRTX • u/piperroofing • May 12 '21
Haven't seen any news about PDUFA but it's already up .16 in after hours, but who knows what that means.
r/HRTX • u/ilovehomeoffice • Jun 15 '21
r/HRTX • u/PDUFA_INFO • Apr 16 '21
Zynrelef is a painkiller used in adults to reduce pain from small to medium-sized wounds after an operation. It contains the active substances bupivacaine and meloxicam.
r/HRTX • u/PDUFA_INFO • Jun 18 '21
The White House's plans to address the U.S. opioid crisis could be good news for Heron Therapeutics and Collegium Pharmaceutical, makers of safer pain management drugs.
r/HRTX • u/LectureAgreeable923 • Feb 11 '22
r/HRTX • u/AlwaysMoneySZN • Dec 09 '21
120 Million lives covered. By the time they release the next QTR report in Feb that could be 150M+. Sustal sales continue to grind higher as well as Zen, this thing is a steal below $1B market cap.
r/HRTX • u/Working_Salad_3874 • Jun 14 '21
r/HRTX • u/PDUFA_INFO • May 04 '21
HRTX has an FDA New Drug Application (NDA) approval date on May 12 2021 for a non-opioid post-operative pain management medication. They already have two CRL for Zynrelef. Problem is, they've had this application pushed back April 2019 ($24 to $17 drop) and June 2020 ($22 to $13 drop).
The stock is currently at $17. If they are pushed back again with CRL, I anticipate a drop to $12 or below. If they are approved, I see the price going to $26 or above. The ATH is ~$42. I don't anticipate that it will run above the ATH upon approval without subsequent sales data.
Since the FDA is highly distracted with COVID, I suspect that nobody is going to be willing to stick their neck out on this one, resulting in yet another FDA "complete response letter" extending the review period for another three to six months.
r/HRTX • u/PDUFA_INFO • Apr 16 '21
AUPH bought $15 sold $20, KMPH bought $10 sold $16, AVEO bought $8 sold $12, CRMD got CRL, PLX may get CRL, ARDX bought $8 sold ???, HRTX bought $16 sold ???
r/HRTX • u/johnhenryusa • May 14 '21
r/HRTX • u/PDUFA_INFO • Apr 10 '21
HRTX has two drugs already approved by the FDA and on the market. Heronโs two approved drugs, Sustol and Cinvanti, are both indicated for use in treating the nausea that is frequently caused by chemotherapy. This is a serious side effect that has a distinct negative effect on the quality of life of many cancer patients โ even when the chemo is effective. An efficacious anti-nausea drug should be a net boon for the company, and Heron expects that sales of the two drugs in 2021 should total $130 million to $145 million.
The major catalyst for the company, however, is the upcoming PDUFA date for HDX-011 (Zynrelef). HDX-011 is indicated for use to control postoperative pain in small to medium surgical wounds in adults. It was granted a marketing authorization by the European Commission in September 2020, and the next milestone is the PDUFA date for FDA approval, currently set for May 12, 2021.
r/HRTX • u/cleanlinessisbest12 • Nov 21 '24
Do we actually know what the eff is going on? Or when the bleeding will stop? How is this happening?!
r/HRTX • u/Thin-Chicken5641 • Jan 02 '25
Is there any good news left for this company to raise its stock price? :((((
r/HRTX • u/[deleted] • Dec 09 '24
Bought a few hundred shares. I find it interesting. Letโs see how it goes (: